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The ingestion of intact protein or essential amino acids (EAA) stimulates mechanistic
target of rapamycin complex-1 (mTORC1) signaling and muscle protein synthesis (MPS)
following resistance exercise. The purpose of this study was to investigate the response
of myofibrillar-MPS to ingestion of branched-chain amino acids (BCAAs) only (i.e., without
concurrent ingestion of other EAA, intact protein, or other macronutrients) following
resistance exercise in humans. Ten young (20.1 ± 1.3 years), resistance-trained men
completed two trials, ingesting either 5.6 g BCAA or a placebo (PLA) drink immediately
after resistance exercise. Myofibrillar-MPS was measured during exercise recovery with a
primed, constant infusion of L-[ring13C6] phenylalanine and collection of muscle biopsies
pre and 4 h-post drink ingestion. Blood samples were collected at time-points before
and after drink ingestion. Western blotting was used to measure the phosphorylation
status of mTORC1 signaling proteins in biopsies collected pre, 1-, and 4 h-post drink.
The percentage increase from baseline in plasma leucine (300 ± 96%), isoleucine
(300± 88%), and valine (144± 59%) concentrations peaked 0.5 h-post drink in BCAA. A
greater phosphorylation status of S6K1Thr389 (P = 0.017) and PRAS40 (P = 0.037) was
observed in BCAA than PLA at 1 h-post drink ingestion. Myofibrillar-MPSwas 22% higher
(P = 0.012) in BCAA (0.110 ± 0.009%/h) than PLA (0.090 ± 0.006%/h). Phenylalanine
Ra was ∼6% lower in BCAA (18.00 ± 4.31 µmol·kgBM−1) than PLA (21.75 ± 4.89
µmol·kgBM−1; P= 0.028) after drink ingestion. We conclude that ingesting BCAAs alone
increases the post-exercise stimulation of myofibrillar-MPS and phosphorylation status
mTORC1 signaling.
Keywords: amino acid ingestion, fractional synthesis rate, intracellular signaling proteins, leucine, muscle
anabolism
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INTRODUCTION
It is well-established that ingestion of essential amino acids
(EAA) following resistance exercise stimulates an increased
response of muscle protein synthesis MPS in humans (Smith
et al., 1998; Tipton et al., 1999a). Indeed, the stimulation of MPS
in humans can be achieved by supplying EAA only (i.e., the
non-EAAs necessary for MPS may be supplied by endogenous
sources) (Tipton et al., 1999b).More recent evidence from studies
in rodents and cell culture models suggest that the stimulation
of MPS by EAA may be mediated by a few amino acids rather
than a combination of all EAA (Crozier et al., 2005; Kimball
and Jefferson, 2006). The branched-chain amino acid (BCAA),
leucine, has been shown to play a unique role in stimulating MPS
(Kimball and Jefferson, 2006). Leucine serves as substrate for the
synthesis of new muscle proteins and as a signal to initiate the
rate-limiting translation initiation step of MPS (Crozier et al.,
2005). Accordingly, the response of MPS to leucine provision has
been extensively investigated over the past two decades, both in
cell culture studies (Buse and Reid, 1975; Kimball and Jefferson,
2006; Atherton et al., 2010b) and in vivo rodent (Anthony et al.,
1999, 2000; Crozier et al., 2005; Norton et al., 2012) and human
(Matthews, 2005; Wilkinson et al., 2013) studies.
The stimulation of MPS is accompanied by an increased
activation of intracellular signaling proteins that regulate the
translational activity of MPS (Philp et al., 2011). In particular,
the mechanistic/mammalian target of rapamycin complex-1
(mTORC1) signaling, often assessed as the phosphorylation
status of the 70 kDa ribosomal S6 protein kinase (S6K1), is
stimulated by ingestion of EAA following resistance exercise
(Dreyer et al., 2008; Moberg et al., 2016). There is current
debate over whether leucine alone (Churchward-Venne et al.,
2014), or the BCAAs combined (Moberg et al., 2016), provide
the most important component of an exogenous EAA source
for stimulating the mTORC1-S6K1 signaling pathway. Whereas,
the inclusion of leucine is necessary for the maximal activation
of mTORC1 signaling (Moberg et al., 2014), recent results
from the same research group show that mTORC1 signaling
is enhanced with the addition of the other two BCAAs, valine
and isoleucine (Moberg et al., 2016). Moreover, there often is
a disconnect between the response of mTORC1 signaling and
MPS (Witard et al., 2009; Atherton et al., 2010a; Glynn et al.,
2010; Macnaughton et al., 2016; McGlory et al., 2016). Thus, the
response of MPS to BCAA ingestion is still uncertain.
In humans, the ingestion of leucine alone has been shown
to stimulate an increased response of MPS at rest (Wilkinson
et al., 2013). Moreover, enriching a “suboptimal” 6.25 g dose
of intact protein with additional leucine has been shown to
increase the response of MPS equivalent to an “optimal” 25 g
protein dose at rest (Churchward-Venne et al., 2012). However,
studies investigating, the influence of leucine co-ingestion with
EAA (Glynn et al., 2010), or intact protein (Koopman et al.,
2005, 2006, 2008; Tipton et al., 2009; Wall et al., 2013) on
the stimulation of MPS in young men report equivocal results.
Whereas, the addition of leucine to whey protein failed to
enhance the post-exercise response of MPS (Koopman et al.,
2005, 2008; Tipton et al., 2009), adding leucine to a casein
protein source was shown to increase the resting postprandial
stimulation ofMPS (Wall et al., 2013).While the response ofMPS
to leucine provision, with or without an intact protein source, is
well-characterized, to our knowledge no study has successfully
determined the response of MPS to the independent ingestion
all three BCAAs (leucine, isoleucine, and valine) combined
(i.e., without concurrent ingestion of intact protein or other
macronutrients) following resistance exercise.
There is ample evidence that BCAA ingestion stimulates
mTORC1 signaling (Karlsson et al., 2004; Apro and Blomstrand,
2010; Moberg et al., 2016), however the post-exercise response
of MPS to BCAA ingestion remains unknown. A recent
investigation with a similar design reported MPS data, but the
very large variability in generated fractional synthetic rate (FSR)
values precluded a solid conclusion from being drawn. Therefore,
given uncertainty due to the known disconnect between signaling
and MPS (Witard et al., 2009; Atherton et al., 2010a) and
previous methodological difficulties in other research groups
(Moberg et al., 2016), the primary aim of the present study
was to determine the response of myofibrillar-MPS to ingestion
of a drink containing BCAAs, but no other EAA, protein, or
macronutrients, following resistance exercise. In addition, we
also measured the phosphorylation status (as a surrogate marker
of activity) of proteins within the mTORC1 signaling pathway
in response to BCAA ingestion. We hypothesized that BCAA
ingestion would increase both the stimulation of myofibrillar-
MPS and the phosphorylation status of mTORC1-S6K1 signaling
proteins following resistance exercise.
MATERIALS AND METHODS
Participants and Ethics Approval
Eleven healthy (body mass: 83.3 ± 11.7 kg; percent lean mass:
86.1 ± 4.1%) young (20.1 ± 1.3 years) men who regularly
participated in resistance training of the lower body (≥2/week
for >1 years) volunteered to participate in the present study. A
priori, we conducted a power calculation (GPower v3 software)
of appropriate sample size based on our previous published
data (Witard et al., 2014) that measured, on average, a 37%
higher post-exercise response of myofibrillar-MPS to 20 g of
ingested whey protein compared with 0 g using the same tracer
technique. The BCAA trial in the present study contained a
similar quantity of BCAAs as the 20 g bolus of whey protein
administered in our previous study (Witard et al., 2014; 5.6
vs. 4.8 g). By setting statistical power (1-ß err prob) at 0.8,
α error probability at 0.05 and effect size (Cohen’s d) at 1.4
(based on our previous data; Witard et al., 2014), our power
calculation revealed a minimum sample size of 10 participants
(using a crossover research design) would be necessary to detect
a statistical difference in myofibrillar-MPS between BCAA and
placebo trials. Due to illness, only 10 participants completed
both experimental trials, therefore all data are shown for 10
participants.
The design, purpose, and potential risks associated with the
study were explained to participants before obtaining written
informed consent. Exclusion criteria were metabolic disorders,
food intolerances/allergies, allergies to local anesthetic, current
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participation in other clinical trials, blood donations within three
months of the initial screening visit, and the prescription of
medication or consumption of nutritional/dietary supplements
suggested to affect protein metabolism. The National Research
Ethics Service board (Warwickshire, Birmingham, UK) approved
all procedures and all were in accordance with the Helsinki
Declaration of 1975 as revised in 1983. This trial is registered as a
clinical trial (registration number: ISRCTN98737111).
Experimental Design
Participants reported to the laboratory on five separate
occasions, including two experimental trials that were
separated by approximately three weeks. During the initial
visit, body composition was assessed using dual-energy x-ray
absorptiometry (DEXA; Hologic Discovery W, Hologic Inc.,
Bedford, Massachusetts, USA) and one repetition maximum
(1RM) was predicted for each leg individually on both leg press
and leg extension. Approximately one week later, participants
returned to the laboratory to confirm their 1RM for each leg.
Three days later, participants performed their first blinded
trial in which they consumed either a BCAA containing drink
(BCAA; GlaxoSmithKline, Brentford, UK) or placebo (PLA)
drink (GlaxoSmithKline, Brentford, UK; Table 1). BCAA
contained 5.6 g of BCAAs which is equivalent to the typical
BCAA content of 20 g whey protein. Participants performed a
unilateral bout of resistance exercise prior to consuming the
test drink in each trial. Myofibrillar-MPS was determined by
measuring the incorporation of L-[ring-13C6] phenylalanine into
myofibrillar protein during a primed continuous infusion. The
complete testing procedure was repeated on the contralateral leg
approximately three weeks after the first trial. Trial and exercised
leg order were counter-balanced and randomized.
Preliminary Testing
Exercise Sessions
At least six days before and <2 week prior to the first infusion
trial, 1RM was predicted for both legs of each participant on the
leg press and leg extension using a previously published method
(Verdijk et al., 2009). Briefly, volunteers warmed up each leg
before completing the maximum number of repetitions at 80%
of predicted 1RM. This exercise load was then inserted into an
TABLE 1 | Nutritional composition of drinks.
PLA BCAA
Calories (Kcal) 13 13
Leucine (g) 0 2.6
Isoleucine (g) 0 1.4
Valine (g) 0 1.6
Carbohydrate (g) 4.6 3.1
Fat (g) 0.02 0.01
Sodium (g) 0.2 0.2
Drinks were consumed after a unilateral bout of resistance exercise and were either a
branched-chain amino acid containing drink (BCAA) or a placebo (PLA) drink. BCAA
contained 5.6 g of branched-chain amino acids which is equivalent to the typical
branched-chain amino acid content of 20 g whey protein.
equation as previously reported to estimate 1RM (Mayhew et al.,
1995).
Three days prior to both infusion trials, participants returned
to the laboratory to confirm their 1RM on both exercises
(Kraemer and Fry, 1995) on the leg that was to be exercised
in the forthcoming trial. Briefly, the load was set to 90% of
estimated 1RM from the previous session. Participants completed
the maximum number of repetitions possible. The load was then
increased by 5–10% until only one repetition could be completed.
A rest period of 3 min was given between each load.
Body Composition, Dietary Control, and
Physical Activity
During the initial visit, body composition (total and segmental)
was assessed using DEXA. Prior the experimental trial,
participants completed a questionnaire of food preferences and a
3-day diet diary that represented their habitual daily intakes. The
average energy intake (3,392 ± 1,069 kcal) and macronutrient
composition [protein: 2.2 ± 1.0 g·kgBM−1·d−1; carbohydrate:
4.7 ± 1.6 g·kgBM−1 ·d−1; fat: 1.4 ± 0.4 g·kgBM−1·d−1] from
the 3 day diet diary was used to calculate the participant’s diet
before the experimental trial. Food parcels, which matched each
participant’s habitual energy and macronutrient intakes, were
supplied for 48 h before the experimental trial. Participants
were instructed to consume only food and drink sources
provided by investigators and to consume their final meal
no later than 22:00 on the evening before the experimental
protocol. Analyses of the diet diary and food prescription were
performed by using a commercially available software program
(Wisp v3; Tinuviel software). All participants were instructed to
refrain from physical exercise for 48 h before the experimental
trial.
Experimental Protocol
A schematic diagram of the experimental protocol is displayed
in Figure 1. Participants reported to the laboratory at ∼06:15
following an overnight fast and measurements of height and
weight were collected. A cannula was inserted into a forearm
vein of one arm, and a resting blood sample was collected.
Thereafter, participants were fed a standardized energy-rich
(7 ± 1 kcal·kgBM−1), high protein (30 ± 1% of energy
from protein, 50 ± 1% of energy from carbohydrate, and
20 ± 1% of energy from fat) breakfast. After breakfast a
primed, continuous infusion (prime: ∼88 µmol·kg−1; infusion
rate: ∼0.227 µmol·kgBM−1·min−1) of 15N2 urea was started
and continued throughout the protocol. Subjects rested for
∼75 min before a primed, continuous (2.0 µmol·kg−1;
infusion ∼0.05 µmol·kgBM−1.min−1) infusion of L-ring 13C6
phenylalanine (both Cambridge Isotope Laboratories Inc.,
Andover, Massachusetts, USA) was started.
Approximately 105 min later, participants performed a single
bout of unilateral leg resistance exercise which lasted ∼25 min.
Participants completed a warm up on the leg press machine
(Cybex VR3, Cybex International, Medway, Massachusetts,
USA), which consisted of 12 repetitions at 40% 1RM, 10
repetitions at 50% 1RM, eight repetitions at 60% 1RM, and
two repetitions at 70% 1RM. The warm up was followed by
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FIGURE 1 | Schematic diagram of the infusion protocol. A baseline blood sample was collected before participants consumed an energy-rich, high-protein breakfast.
A bout of unilateral leg-resistance exercise was performed 3 h after breakfast. Muscle biopsies (vastus lateralis) were collected from the exercised leg immediately prior
(0 h), 1-, or 4 h-post drink ingestion. Drink ingestion was either a branched-chain amino acid containing beverage (BCAA) or placebo (PLA). Multiple blood samples
were collected throughout the protocol. Ex, exercise.
a 2 min rest period. The resistance exercise protocol consisted
of four sets of 10 repetitions at 70% 1RM on the leg press
machine and four sets of 10 repetitions at 75% 1RM on the leg
extension machine (Cybex VR3, Cybex International, Medway,
Massachusetts, USA). Participants rested for 2 min between each
set and were free to consume water ad libitum. If a participant
could not complete a full set, the load was lowered by 4.5 kg.
Rating of perceived exertion (RPE) using the modified Borg scale
(Borg, 1973) was measured after each set. Immediately (∼5 min)
after exercise (t = 0 min), an arterialized blood sample and a
muscle biopsy were collected followed by ingestion of the test
drink. Blood samples also were collected at multiple time points
(t =−240,−145,−85,−25, 0, 15, 30, 45, 60, 75, 90, 120, 150, 180,
240min) before and after drink ingestion. Two further muscle
biopsies were collected 1 and 4 h after drink ingestion.
Muscle Biopsy Collection and Analysis
Muscle biopsies were obtained from the vastus lateralis of
the exercised leg under local anesthesia (1% lidocaine) using
5 mm Bergstrom needles with suction. Different incisions
(∼1 cm apart, proximally from previous site) were used for
each biopsy in an attempt to minimize the impact of local
inflammation from the previous biopsy sample. Biopsy samples
were immediately rinsed, blotted of excess blood, removed of
visible fat and connective tissue, and divided into aliquots,
before being frozen in liquid nitrogen, and stored at –80◦C until
later analysis. Muscle samples were analyzed for enrichment
of L-[ring-13C6] phenylalanine in the intracellular pool and
bound myofibrillar protein fractions, Furthermore, muscle was
analyzed to measure the phosphorylation status of mTORC1-
related signaling proteins.
Myofibrillar Protein Enrichment
Muscle tissue was analyzed for enrichment of L-[ring-13C6]
phenylalanine in the myofibrillar protein fraction. Myofibrillar
proteins were isolated from ∼30mg tissue as previously
described (Moore et al., 2009). Briefly muscle was snipped in
ice-cold homogenizing buffer (50 mM Tris-HCL, 1 mM EDTA,
1 mM EGTA, 10 mM β-glycerophosphate, and 50 mM sodium
fluoride). The homogenate was shaken for 10 min prior to being
centrifuged at 1,000 g for 10 min at 4◦C. The pellet was then
re-suspended in homogenization buffer, before being shaken and
centrifuged as described above. The myofibrillar fraction was
separated from any collagen by dissolving the pellet in 0.3 M
NaCl and heating for 30 min at 37◦C. The proteins were then
precipitated by combining the supernatant with 1 M PCA before
being centrifuged for 20 min at 3500 rpm at 4◦C. The pellet
was then washed with 70% ethanol. The remaining myofibrillar
pellet was hydrolyzed overnight at 110◦C in 0.1 M HCl/Dowex
50W-X8 100–200 (Bio-Rad laboratories Inc., USA) and the
liberated amino acids purified on cation-exchange columns (Bio-
Rad laboratories Inc., USA). Amino acids were then converted
to their N-acetyl-n-propyl ester derivative and phenylalanine
labeling was determined by gas-chromatography-combustion-
isotope ratio mass spectrometry (GC-C-IRMS, Delta-plus XL,
Thermofinnigan, Hemel Hempstead, UK). Ions 44/45 were
monitored for unlabeled and labeled CO2, respectively.
Intracellular Phenylalanine Enrichment
Intracellular amino acids were liberated from ∼20mg of muscle.
The frozen tissue was powdered under liquid nitrogen using a
mortar and pestle and 500 µL of 1 M perchloric acid (PCA)
was added. The mixture was centrifuged at 10,000 g for 10
min. The supernatant was then neutralized with 2 M potassium
hydroxide and 0.2M PCA and combined with 20µL of urease for
removal of urea. The free amino acids from the intracellular pool
were purified on cation-exchange columns as described above.
Intracellular amino acids were converted to their MTBSTFA
derivative and 13C6 phenylalanine enrichment was determined
by monitoring at ions 234/240 using gas chromatography
mass spectrometry (GCMS; model 5973; Hewlett Packard, Palo
Alto, CA).
Western Blotting
Muscle tissue (20–30 mg) was powdered on dry ice and then
homogenized in lysis buffer (50 mM Tris pH 7.5; 250 mM
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Sucrose; 1 mM EDTA; 1 mM EGTA; 1% Triton X-100; 1 mM
NaVO4; 50 mMNaF; 0.50% PIC) using a hand-held homogenizer
(PRO200, UK). Samples were placed on a shaker for 1 h at 4◦C,
before being centrifuged for 5 min at 6,000 g. The supernatant
was then used for determination of protein. A DC protein assay
(Bio Rad, Hertfordshire, UK) was used for determining protein
concentration. Equal amounts of protein were then boiled in
Laemmli sample buffer (250 mM Tris-HCl, pH 6.8; 2% SDS; 10%
glycerol; 0.01% bromophenol blue; 5% β-mercaptoethanol) and
separated on SDS polyacrylamide gels (10–15%) for ∼1 h at 58
mA. Proteins were then transferred to a Protran nitrocellulose
membrane (Whatman, Dassel, Germany) at 100 V for 1 h.
Membranes were blocked usingmilk solution and then incubated
overnight at 4◦C with the appropriate primary antibody.
The primary antibodies used were: S6K1Thr389 (Cell signaling
#9234); AktSer473 (Cell signaling #3787); 4E-BP1Thr37/45 (Santa
Cruz SC6025); and PRAS40Thr246 (Cell Signaling #2610). The
following morning the membrane was rinsed in wash buffer
(TBS with 0.1% Tween-20) before being incubated for 1 h at
room temperature with the appropriate secondary antibody;
either horseradish (HRP)-linked anti-mouse IgG (New England
Biolabs, 7072;1:1,000) or anti-rabbit IgG (New England Biolabs,
7074; 1:1,000) diluted in wash buffer. The membrane was then
cleared of the antibody using wash buffer. Antibody binding
was detected using enhanced chemiluminescence (Millipore,
Billerica, MA). Imaging and band quantification were carried out
using a Chemi Genius Bioimaging Gel Doc System (Syngene,
Cambridge, UK). Blots were stripped in RestoreTM Western Blot
Stripping Buffer (Pierce, Rockford, IL) for 20min and, re-blocked
in milk solution and the respective total protein antibodies [S6K1
(Santa Cruz #sc-230); Akt (Cell signaling #9272); 4E-BP1 (Santa
Cruz #sc-4251); and PRAS40 (Cell Signaling #2691)] were used
to assure equal loading.
Blood Collection and Analysis
Blood was collected in lithium heparin, EDTA-containing and
serum separator tubes and centrifuged at 3,500 rpm for 15 min
at 4◦C. Aliquots of plasma and serum were then frozen at−80◦C
until later analysis. Plasma glucose and urea concentrations
were analyzed using an instrumentation laboratory automated
blood metabolite analyzer (Instrumentation Laboratory 650,
Instrumentation Laboratory, Cheshire, UK). Serum insulin
concentrations were measured using a commercially available
ELISA (DRG Diagnostics, USA) following manufacturer’s
instructions.
Plasma Amino Acid Concentrations and
Enrichments
The 13C6 enrichments of phenylalanine and tyrosine were
determined by GCMS by monitoring ions 234 and 240 for
unlabeled and labeled phenylalanine and ions 466 and 472 for
unlabeled and labeled tyrosine. Once thawed, plasma samples
were mixed with diluted acetic acid and purified using a cation-
exchange column (Bio-Rad laboratories Inc., USA). The amino
acids were then converted to their N-tert-butyldimethyl-silyl-N-
methyltrifluoracetamide (TBDMS) derivative.
Simultaneously, concentrations of phenylalanine, leucine,
threonine, isoleucine, and valine were determined using
an internal standard method (Tipton et al., 1999b, 2001).
The selected amino acids were chosen to monitor blood
concentrations of essential, non-essential, and the BCAAs.
Briefly, plasma samples were weighed to obtain ∼300 µL, 30µL
of an internal standard containing U-13C9-
15N phenylalanine
(ions 336/346), U-13C6 leucine, and isoleucine (ions 302/308),
U-13C4-
15N threonine (ions 405/409), and U-13C5 valine (ions
288/293) was then added and weighed. Since the weight of
both sample and internal standard was known, it was possible
to calculate a tracer-to-tracee ratio. Since the amino acid
concentrations of the internal standard were known, it was
possible to convert the tracer-to-tracee ratio into a concentration
of each amino acid in plasma.
Plasma Urea Enrichments
To determine 15N2 urea enrichments, 10µL of plasma wasmixed
with 120 µL ethanol. Samples were then left in the fridge for 30
min prior to centrifugation at 13,000 rpm for 20 min at 4◦C.
The supernatant was then removed and dried under nitrogen.
TBDMS and acetonitrile were added to the dried sample prior
to heating at 90◦C for 90 min. Samples were then run on GCMS
and ions 231 and 233 were monitored.
Calculations
Myofibrillar MPS
The fractional synthesis rate (FSR) of the myofibrillar protein
fraction was calculated over the 4 h period using the standard
precursor-product equation below:
FSR
(
% · h−1
)
=
(
EB3 − EB1
EIC · t
)
· 100 (1)
Where EB (B3 is the bound
13C6 phenylalanine enrichment
measured in the biopsy collected at the 4h time point, B1
is the bound 13C6 phenylalanine enrichment measured in the
biopsy collected at the 0 h time point), EIC is the average IC
phenylalanine enrichment of biopsies collected at 0 and 4 h, and
t is time of tracer incorporation (h).
Endogenous Urea Production Rates
The rate of urea production over time (µmol·h−1·kgBM−1) was
calculated as previously described (Equation 2; Jahoor andWolfe,
1987).
Production =
((
Eui
Eup
)
− 1
)
· i (2)
where i is the infusion rate of the urea tracer (µmol·h−1·kgBM−1)
and Eup and Eui are the enrichments of urea in the plasma and
infusate, respectively.
Phenylalanine Kinetics
Whole body phenylalanine rate of appearance was calculated by
dividing the infusion rate by plasma phenylalanine enrichment,
as described previously (Tipton et al., 1996). Phenylalanine
oxidation was calculated by using the phenylalanine
balance model (Thompson et al., 1989). Briefly, whole
body phenylalanine oxidation was determined from the
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calculation of the hydroxylation of L-[ring-13C6]phenylalanine
to L-[ring-13C6]tyrosine (Equation 3; Thompson et al., 1989).
Qpt =
Pt
Pp
·
Q2p(
Ep
Et
− 1
)
·
(
ip + Qp
) (3)
Where, Pt/Pp is estimated to be 0.73 (Thompson et al., 1989). Qp
is the phenylalanine flux (µmol·h−1·kgBM−1), i is the infusion
rate of the tracer (µmol·h−1·kgBM−1) and Ep and Et are the
respective enrichments of phenylalanine and tyrosine.
Statistical Analyses and Data Presentation
Total area under the curve (tAUC) for serum insulin
concentrations, phenylalanine Ra, and phenylalanine oxidation
rates were calculated using Graphpad Prism V5.0 (Graphpad
software incorporation, La Jolle, California, USA). tAUC-values
were calculated from drink ingestion to final blood sample and a
baseline y-axis value of zero for each was used.
A two-way repeated measures ANOVA was used to analyse
blood glucose, insulin, amino acid, and urea concentrations,
whole body urea production rates, phenylalanine Ra,
phenylalanine oxidation rates, and phenylalanine/tyrosine
enrichments (within-subject factor: time point; between-subject
factor: trial). Exercise variables, myofibrillar-MPS, and tAUC
of serum insulin concentrations, and phenylalanine kinetics
for the post-exercise period were analyzed using a paired
samples one-tailed t-test. Western blot data were expressed
as percentage change from t = 0 (immediately post-exercise
muscle biopsy) and data were analyzed using a two-way repeated
measures ANOVA. Given the large variability associated with
phosphorylation measurements of anabolic cell signaling, a
priori we decided to explore differences over time for each trial
separately. Significance for all analyses was set at P < 0.05.
Where significance was detected, a LSD correction was used
in post-hoc analysis. All statistical tests were completed using
statistical package for social sciences version 23.0 (IBM, Chicago,
Illinois, USA). All values are presented as means ± SEM, unless
otherwise stated.
RESULTS
Exercise Variables
The lean tissue mass of the exercised leg, measured prior to each
experimental protocol, was similar between trials (P > 0.05). The
total weight lifted throughout the exercise protocol (including
warm-up) was similar between BCAA (11,055± 837 kg) and PLA
(11,089± 913 kg) trials (P= 0.88) and participants reported RPE
scores 19 in all exercise trials.
Blood Glucose, Insulin, and Amino Acid
Concentrations
Plasma glucose concentrations did not change over time
(P = 0.093), were similar between trials (P = 0.365; data not
shown) and no interaction effect was observed (P = 0.548).
In both trials, serum insulin concentrations markedly (264%)
increased (P < 0.01) in response to breakfast, before returning
to baseline 1 h after exercise and remained stable over the
remainder of the recovery period (data not shown). There were
no differences in insulin concentrations between BCAA and PLA
trials (P = 0.48) and no interaction effect was observed (P =
0.36). The insulin tAUC over 4 h following drink ingestion was
similar (P= 0.70) between BCAA (50± 17µIU·mL−1 ∗240min)
and PLA (53± 19 µIU·mL−1 ∗240 min) trials.
A significant time effect was observed for plasma
concentrations of leucine (P< 0.001), isoleucine (P< 0.001), and
valine (P < 0.001; Figure 2). The concentrations of all branched
chain amino acids were greater in BCAA than PLA (P < 0.001).
Peak leucine (624 ± 41 µM), isoleucine (339 ± 23 µM), and
valine (753± 45µM) concentrations were observed at 0.5 h-post
drink ingestion in BCAA.percentage increase from baseline of
300 ± 96% (leucine), 300 ± 88% (isoleucine), and 144 ± 59%
(valine). A significant interaction effect for plasma branched
chain amino acid concentrations was observed whereby over
the entire measurement period after drink ingestion, leucine
(P < 0.001), and valine (P ≤ 0.002) concentrations were greater
in BCAA than PLA. Over a 3.5 h period post drink ingestion,
isoleucine levels were higher in BCAA (P ≤ 0.001).
Phenylalanine and threonine concentrations declined to
below baseline values after drink ingestion in both trials (P <
0.001). There were no difference in threonine concentrations
between trials (P= 0.207) and no interaction effect was observed
(P = 0.056). Phenylalanine concentrations (main effect of trial; P
= 0.003) were significantly higher in BCAA than PLA at 15 min
(83 ± 5 vs. 75 ± 8 µM, P = 0.018), but significantly lower in
BCAA than PLA at 120 min (57 ± 9 vs. 67 ± 8 µM, P = 0.003),
150 min (58± 7 vs. 65± 9 µM, P = 0.007), and 240 min (63± 6
vs. 73± 13 µM, P = 0.021) post drink ingestion.
Blood Urea Concentrations and
Whole-Body Urea Production Rates
A decrease in plasma urea concentrations was observed in both
trials during the latter stage (3–4 h) of exercise recovery (P
< 0.026), with no differences between trials (P = 0.733; data
not shown). Whole body urea production rates decreased from
immediately post-exercise to the end of the 4 h recovery period
(P < 0.001; data not shown), however there was no differences
between trials (P= 0.685) and no interaction effect was observed
(P = 0.611). The tAUC of urea production in response to post-
exercise drink ingestion was similar between BCAA (2,314± 490
µmol·kgBM−1) and PLA (2,272± 636µmol·kgBM−1 P= 0.694)
trials.
Amino Acid Enrichments
Muscle intracellular and blood plasma 13C6 phenylalanine
enrichments were stable over the measured time period of
tracer incorporation (0–4 h) in both trials (Figure 3). Plasma
13C6 tyrosine enrichments increased over time during the
experimental protocol (data not shown). Trial order had no effect
on intracellular and plasma tracer enrichments.
Whole Body Phenylalanine Kinetics
Phenylalanine Ra, expressed as tAUC over the post drink period,
was 6% lower in BCAA than PLA (P= 0.028). In addition, tAUC
Frontiers in Physiology | www.frontiersin.org 6 June 2017 | Volume 8 | Article 390
Jackman et al. BCAA Ingestion and Muscle Protein Synthesis
FIGURE 2 | Plasma concentrations of (A) leucine, (B) isoleucine, (C) valine, (D) phenylalanine, and (E) threonine pre and post ingestion of either a branched-chain
amino acid containing drink (BCAA, closed circles) or placebo drink (PLA, open circles) following resistance exercise. Data are displayed as means ± SE. *Significant
difference between trials (P < 0.05).
FIGURE 3 | Muscle intracellular (A) and plasma (B) 13C6 phenylalanine enrichments pre and post ingestion of either a branched-chain amino acid containing drink
(BCAA, black circles) or placebo drink (PLA, white circles) following resistance exercise. Data are displayed as means ± SE.
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of whole body phenylalanine oxidation rate was 16% lower in
BCAA compared with PLA (P = 0.006, Figure 4).
Anabolic Signaling Proteins
Signaling data are displayed in Figure 5. The phosphorylation of
AKTSer473 increased over time (P = 0.025). However, there was
no trial effect (P = 0.388). The phosphorylation of AKTSer473
increased at 1 h compared with 0 h in BCAA (P= 0.007). Further,
phosphorylation of AKTSer473 was higher at 1 h compared with
4 h in BCAA (P= 0.015) but there were no differences between 0
and 4 h in BCAA (P= 0.903). There were no differences between
0 and 1 h (P= 0.056) or 4 h (P= 0.174) and 1 and 4 h (P= 0.085)
in PLA.
The phosphorylation of PRAS40Thr246 increased over time
(P = 0.022). However, there was no trial effect (P = 0.281).
The phosphorylation of PRAS40Thr246 increased ∼12-fold at
1 h compared with 0 h in BCAA (P = 0.037). Further
phosphorylation of PRAS40Thr246 was higher at 1 h compared
with 4 h in BCAA (P = 0.047) but there were no differences
between 0 and 4 h in BCAA (P = 0.102). There were no
differences between 0 and 1 h (P = 0.050) or 4 h (P = 0.101)
and 1 and 4 h (P= 0.112) in PLA.
The phosphorylation of S6K1Thr389 increased over time
(P = 0.021). However, there was no trial effect (P =
0.087). The phosphorylation of S6K1Thr389 increased ∼6-fold
at 1 h compared with 0 h in BCAA (P = 0.017). Further,
phosphorylation of S6K1Thr389 was higher at 1 h compared with
4 h in BCAA (P= 0.014) but there were no differences between 1
and 4 h in BCAA (P= 0.690). There were no differences between
0 and 1 h (P= 0.120) or 4 h (P= 0.05)0 and 1 and 4 h (P= 0.795)
in PLA.
The phosphorylation of 4EBP1Thr37/45 remained constant
over time (P = 0.115) and there were no trial effect (P = 0.566).
Muscle Myofibrillar Protein Synthesis
Myofibrillar FSR was ∼22% higher (P = 0.012) in BCAA than
PLA over the 4 h period following drink ingestion (Figure 6).
DISCUSSION
The present study demonstrated that ingesting of all three
BCAAs alone, without concurrent ingestion of other EAA,
protein, or macronutrients, stimulated a 22% greater response
of myofibrillar-MPS following resistance exercise compared
with a placebo. The magnitude of this increased response of
myofibrillar-MPS was ∼50% less than the previously reported
myofibrillar-MPS response to a dose of whey protein containing
similar amounts of BCAAs (Churchward-Venne et al., 2012;
Witard et al., 2014). Taken together, these results demonstrate
that BCAAs exhibit the capacity to stimulate myofibrillar-MPS,
however a full complement of EAA could be necessary to
stimulate a maximal response of myofibrillar-MPS following
resistance exercise. This information potentially has important
nutritional implications for selecting amino acid supplements to
facilitate skeletal muscle hypertrophy in response to resistance
exercise training and the maintenance of muscle mass during
aging, unloading, or disease.
The most likely physiological explanation for the apparent
attenuation of the post-exercise response of myofibrillar-MPS
to BCAA ingestion in comparison to an intact protein source
relates to the limited availability of amino acids as substrate
for MPS. It is well-established that BCAA ingestion stimulates
the activation of mTORC1 signaling pathways that regulate
the translational activity of MPS (Karlsson et al., 2004; Apro
and Blomstrand, 2010; Moberg et al., 2016). Moreover, recent
results demonstrate that the presence of the valine and isoleucine
enhances the response of mTORC1 to leucine (Moberg et al.,
2016). However, results from the present study suggest that
ingesting BCAAs alone, without the other EAA, provides limited
substrate for protein synthesis in exercised muscles. Thus, the
overall response of MPS is not maximized. Instead, the limited
availability of EAA likely explains the qualitative difference in
magnitude of the MPS response to ingestion of BCAAs alone
and ingestion of similar amounts of BCAAs as part of intact
whey protein (Churchward-Venne et al., 2012, 2014; Witard
et al., 2014). Moreover, in the present study, we observed a
FIGURE 4 | Phenylalanine kinetics, expressed as, total area under the curve for phenylalanine rate of appearance (A) and total area under the curve for phenylalanine
oxidation (B) following the post-exercise ingestion of a branched-chain amino acid (BCAA, black bars) or placebo drink (PLA, white bars). Data are displayed as
means ± SE. *Significant difference compared with PLA (P < 0.05).
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FIGURE 5 | Phosphorylation status of, AKTSer473 (A), PRAS40Thr246 (B), S6K1Thr389 (C), and 4EBP1Thr37/45 (D) immediately pre (0 h), 1-, and 4 h-post ingestion
of either a branched-chain amino acid containing drink (BCAA, black bars) or placebo drink (PLA, white bars) following resistance exercise. Data are displayed as
means ± SE. #Significant difference from 0 h in respective trials (P < 0.05).
decline in arterialized phenylalanine concentrations 3 h after
drink ingestion in the BCAA trial. This finding is consistent with
previous research that observed decreased EAA concentrations
following leucine ingestion (Hagenfeldt and Wahren, 1980; Nair
et al., 1992; Tipton et al., 2009; Borgenvik et al., 2012). Taken
together, these data support the notion that EAA availability is
the rate-limiting factor for stimulating a maximal MPS response
to resistance exercise with BCAA ingestion.
The decline in EAA availability that we observed with BCAA
ingestion also provides a potential physiological explanation for
the differential response of MPS to ingesting a BCAA source
at rest and following resistance exercise. Previously, Wilkinson
and colleagues reported an ∼100% increase in myofibrillar-MPS
in response to ingestion of leucine alone at rest (Wilkinson
et al., 2013). Furthermore, a study from Churchward-Venne and
colleagues reported that adding leucine to a “suboptimal” dose
(6.25 g) of whey protein resulted in rates of myofibrillar-MPS
similar to those after ingestion of 25 g of whey protein at rest.
However, consistent with the results reported in the present
study, the addition of leucine to 6.25 g of whey protein was not as
effective as higher doses of whey protein ingested after resistance
exercise (Churchward-Venne et al., 2012). Thus, exercise has
been shown to alter the relationship of the MPS response to
ingested leucine and intact protein. It is likely that the enhanced
ability of muscle to utilize ingested protein following exercise
(Pennings et al., 2011; Witard et al., 2014) leads to a greater
demand for EAA, thus resulting in limited EAA availability at
the greater rates of MPS. In another study, Churchward-Venne
et al. (2014) also reported that BCAA added to a suboptimal dose
of whey protein resulted in less stimulation of MPS than when
the same amount of leucine alone was added to suboptimal whey
protein. These data suggest that leucine alone may be sufficient
to stimulate MPS following exercise provided a minimal amount
of EAA is included. However, Churchward-Venne et al. (2014)
included ingestion of leucine with 6.25 g of whey protein and a
mixed macronutrient beverage making direct comparisons with
our results difficult. Leucine seems to be the most important
BCAA for stimulation of the translation initiation pathways
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FIGURE 6 | Muscle myofibrillar fractional synthesis rate following the
post-exercise ingestion of a branched-chain amino acid containing drink
(BCAA) or placebo drink (PLA). Data are displayed as means (bars) and
individual responses (dots and lines). *Significant difference compared with
PLA (P < 0.05).
(Anthony et al., 2000; Crozier et al., 2005) and leucine alone
stimulatesMPS at rest (Wilkinson et al., 2013). Thus, it is possible
that leucine is solely responsible for the stimulation in MPS
we report here. On the other hand, recent data suggest that
there is a greater stimulatory effect on mTORC1 when valine
and isoleucine are consumed alongside leucine (Moberg et al.,
2016). Nevertheless, taken together, these past and present data
suggest that the availability of EAA may be a critical factor for
the optimal response of MPS following resistance exercise. Since
the ingestion of BCAAs alone stimulates myofibrillar-MPS, but
does not increase the supply of all EAA, the overall response of
myofibrillar-MPS following resistance exercise is limited.
The influence of exogenous BCAAs on the stimulation of
MPS following exercise is mediated by an increased activation of
the mTORC1-S6K1 signaling pathway. In the present study, the
stimulation of PRAS40Thr246, and S6K1Thr389 phosphorylation
1 h following drink ingestion was higher in BCAA than PLA.
Thus, our results are consistent with earlier work demonstrating
an upregulation of translational activity with BCAA ingestion
(Karlsson et al., 2004; Apro and Blomstrand, 2010). The present
study is the first to demonstrate the upregulation of mTORC1
signaling with BCAA ingestion translates into an increased
response of myofibrillar-MPS following resistance exercise.
BCAAs has been shown to influence muscle protein
metabolism through MPB as well as MPS (Buse and Reid,
1975; Louard et al., 1990; Wilkinson et al., 2013). Early
studies demonstrated that BCAAs reduce whole-body protein
breakdown (Ferrando et al., 1995) and MPB (Louard et al., 1990;
Nair et al., 1992). Recent evidence suggests the impact of BCAAs
on MPB may be mediated by the leucine metabolite, β-hydroxy-
β-methylbutyrate (Wilkinson et al., 2013). However, to date no
study has investigated the impact of BCAA supplementation on
MPB following exercise. Unfortunately, it was not possible to
directly measure MPB in the present study, however our data
suggest that whole-body protein breakdown was reduced by
BCAA ingestion. Whereas, urea production rates were similar
between trials, phenylalanine Ra, and phenylalanine oxidation
rates—both indicators of whole body protein catabolism—were
lower in BCAA than PLA during the 4 h period after drink
ingestion. These data are consistent with previously reported
results following ingestion of intact protein with similar amounts
of BCAAs (Witard et al., 2014). It has been reported that MPB
is reduced by insulin following resistance exercise (Biolo et al.,
1999). However, the insulin response to BCAA and PLA was
similar, so it is unlikely that insulin explains the decline in whole-
body protein breakdown following BCAA ingestion. Thus, it
seems clear that whole-body protein breakdown is decreased,
albeit minimally, with ingestion of BCAAs following resistance
exercise. However, these results do not necessarily mean that
MPB is decreased with BCAA ingestion.
To conclude, the ingestion of BCAAs alone, without the
concurrent ingestion of other EAA, intact protein or other
macronutrients, increases the stimulation of mTORC1 activity
and myofibrillar-MPS following exercise in resistance-trained
young men. Our data support the notion that BCAA ingestion
alone does not maximally stimulate myofibrillar-MPS following
exercise despite stimulation of translation initiation pathways.
The lack of sufficient EAA appears to limit the response
of myofibrillar-MPS following exercise. Thus, whereas our
data clearly show that BCAA ingestion activates cell-signaling
pathways that result in increased myofibrillar-MPS, ingestion of
BCAAs alone may not be the optimal nutritional regimen to
stimulate amaximalMPS response to resistance exercise training.
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